Project Grant R01AI187524
Award Date
12/13/24
Completion Date
11/30/29
Dollars Obligated
$638K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
This $173,030 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The funding supports the development of a novel assay for receptor-guided discovery of environmental bacteriophages (phages) using co-culture techniques. The project aims to create a generalized method to identify phages that require specific bacterial membrane proteins or structures for infection, which could aid...
This federal Project Grant award for $967,980 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The grant supports research by Harvard Medical School to investigate evolutionary tradeoffs in antibiotic resistance. The key objectives are to study how the accumulation of resistance mutations affects bacterial fitness, how plasmids and mobile genetic elements impact resistance evolution, and how...
This federal Project Grant award for $637,275 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to uncover the mechanisms behind how gram-negative bacterial pathogens rapidly develop tolerance to chemical stressors like antibiotics. The research aims to determine how bacteria can inhibit the functioning of existing porin proteins in their outer membrane within minutes of exposure to...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $125,160 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Ohio State University to characterize a novel bacterial immune system with unknown mechanisms. The grant will fund research to define the structure and assembly mechanisms of a two-component system, named A and B, that forms a large complex for anti-phage defense. The project will utilize cryogenic electron microscopy...
This $193,375 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to investigate the role of the ESX1 secretion system in Mycobacterium tuberculosis (MTB) and its impact on treatment outcomes. The primary objectives are to use bacterial genetic approaches to assess the effects of clinically prevalent ESX1 variants on function in vitro, and to leverage mouse and...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $220,340 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Carnegie Institution of Washington for the project "Coordinated Growth in Microbial Communities and Implications for Antibiotic Sensitivities". This research aims to understand how cross-phylum signals between Lactiplantibacillus plantarum and Acetobacter species affect cellular physiology and antibiotic...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA 93.310 (Trans-NIH Research Support) provides $1,148,000.00 to The Trustees of Princeton University to develop novel approaches for combating bacterial infections and antibiotic resistance. The key products/services to be delivered include: Utilizing single-cell RNA sequencing methods (M3-SEQ and Dual-M3-SEQ) to monitor host-pathogen interactions and phage dynamics at the single-cell level,...
This $747,763 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop small molecule inhibitors of the LPXH enzyme as novel antibiotics for treating multidrug-resistant Enterobacterales infections. The five-year project, running from May 2025 to April 2030, leverages the awardee Duke University's expertise in LPXH inhibitor development to design potent compounds with...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $749,417 to support research focused on the development of novel bactericidal antibiotics targeting the lipoprotein transport pathway in Gram-negative bacteria. The research aims to diversify and improve an existing modular antibiotic platform to synthesize new candidate antibiotics with enhanced potency and...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $569,210 to the University of Colorado Boulder to characterize the biochemical mechanisms of antimicrobial resistance in Gram-negative bacteria. The project aims to structurally and functionally analyze three key enzymes involved in modifying the bacterial cell membrane component lipid A, which confers...